United States· US:50419-331_7c4d8f12-64e0-465f-9b4b-99700e141feb
Ambelvist
A gadoquatrane product containing gadoquatrane, registered in United States by Bayer HealthCare Pharmaceuticals Inc.. The same ATC class is registered in 3 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Gadoquatrane is registered in 3 of 19 countries.
Countries holding a registration under ATC V08CA13 (gadoquatrane), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Gadoquatrane · ATC V08CA13
3 / 19 countries
- Japan
- Switzerlandprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- GADOQUATRANE
- Manufacturer
- Bayer HealthCare Pharmaceuticals Inc.
- Country
- United States (US)
- ATC code
- V08CA13
- ATC class
- Gadoquatrane
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1150419-331-11
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Gadoquatrane in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/17bf86c1-0ec1-489b-9449-c9ef7e2ec229 GET /v1/drugs/17bf86c1-0ec1-489b-9449-c9ef7e2ec229?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "257.9",
"substance": "GADOQUATRANE",
"productndc": "50419-331",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "NDA219627",
"marketing_category": "NDA"
}See everything about gadoquatrane.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.